RAPT Historical Income Statement
| RAPT Stock | USD 8.33 0.20 2.46% |
Historical analysis of RAPT Therapeutics income statement accounts such as Other Operating Expenses of 71.6 M, Research Development of 57 M, Total Operating Expenses of 71 M or Reconciled Depreciation of 944.2 K can show how well RAPT Therapeutics performed in making a profits. Evaluating RAPT Therapeutics income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of RAPT Therapeutics's future profits or losses.
Financial Statement Analysis is much more than just reviewing and examining RAPT Therapeutics latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether RAPT Therapeutics is a good buy for the upcoming year.
RAPT |
About RAPT Income Statement Analysis
RAPT Therapeutics Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to RAPT Therapeutics shareholders. The income statement also shows RAPT investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).
RAPT Therapeutics Income Statement Chart
RAPT Therapeutics Income Statement is one of the three primary financial statements used for reporting RAPT's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of RAPT Therapeutics revenue and expense. RAPT Therapeutics Income Statement primarily focuses on the company's revenues and expenses during a particular period.
At this time, RAPT Therapeutics' Depreciation And Amortization is comparatively stable compared to the past year. Interest Expense is likely to gain to about 1.3 M in 2024, whereas Other Operating Expenses is likely to drop slightly above 71.6 M in 2024. Add Fundamental
Other Operating Expenses
Other Operating Expenses is the expense which generally does not depend on sales or production quantities of RAPT Therapeutics. It is also known as RAPT Therapeutics overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.Total Operating Expenses
The total costs associated with the day-to-day operations of a business, excluding the cost of goods sold but including selling, general, and administrative expenses.Most accounts from RAPT Therapeutics' income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into RAPT Therapeutics current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in RAPT Therapeutics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in american community survey. For more information on how to buy RAPT Stock please use our How to Invest in RAPT Therapeutics guide.At this time, RAPT Therapeutics' Depreciation And Amortization is comparatively stable compared to the past year. Interest Expense is likely to gain to about 1.3 M in 2024, whereas Other Operating Expenses is likely to drop slightly above 71.6 M in 2024.
| 2021 | 2022 | 2023 | 2024 (projected) | Reconciled Depreciation | 996K | 1.0M | 1.1M | 944.2K | Total Operating Expenses | 73.0M | 87.3M | 123.5M | 71.0M |
RAPT Therapeutics income statement Correlations
Click cells to compare fundamentals
RAPT Therapeutics Account Relationship Matchups
High Positive Relationship
High Negative Relationship
RAPT Therapeutics income statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Depreciation And Amortization | 1.3M | 1.1M | 996K | 1.0M | 3.6M | 3.7M | |
| Interest Expense | 2.6M | 2.4M | 996K | 1.0M | 1.2M | 1.3M | |
| Selling General Administrative | 8.7M | 12.8M | 16.0M | 20.2M | 26.1M | 14.6M | |
| Other Operating Expenses | 43.6M | 58.3M | 73.0M | 87.3M | 127.1M | 71.6M | |
| Operating Income | (43.6M) | (53.2M) | (69.2M) | (85.8M) | (127.1M) | (120.7M) | |
| Net Income From Continuing Ops | (43.0M) | (52.9M) | (69.2M) | (83.8M) | (108.9M) | (103.4M) | |
| Ebit | (43.6M) | (53.2M) | (69.2M) | (85.8M) | (127.1M) | (120.7M) | |
| Research Development | 34.9M | 45.5M | 57.0M | 67.1M | 101.0M | 57.0M | |
| Ebitda | (42.3M) | (52.1M) | (68.2M) | (84.7M) | (123.5M) | (117.3M) | |
| Total Operating Expenses | 43.6M | 58.3M | 73.0M | 87.3M | 123.5M | 71.0M | |
| Reconciled Depreciation | 1.3M | 1.1M | 996K | 1.0M | 1.1M | 944.2K | |
| Income Before Tax | (42.3M) | (51.9M) | (69.2M) | (83.8M) | (116.8M) | (111.0M) | |
| Total Other Income Expense Net | 1.3M | 1.3M | 5K | 2.0M | 10.3M | 10.8M | |
| Net Income Applicable To Common Shares | (43.0M) | (52.9M) | (69.2M) | (83.8M) | (75.5M) | (79.2M) | |
| Net Income | (43.0M) | (52.9M) | (68.2M) | (81.9M) | (116.8M) | (111.0M) | |
| Income Tax Expense | 660K | 990K | (996K) | (2.0M) | (1.8M) | (1.7M) |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards RAPT Therapeutics in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, RAPT Therapeutics' short interest history, or implied volatility extrapolated from RAPT Therapeutics options trading.
Currently Active Assets on Macroaxis
When determining whether RAPT Therapeutics is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if RAPT Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Rapt Therapeutics Stock. Highlighted below are key reports to facilitate an investment decision about Rapt Therapeutics Stock:Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in RAPT Therapeutics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in american community survey. For more information on how to buy RAPT Stock please use our How to Invest in RAPT Therapeutics guide.You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.
Complementary Tools for RAPT Stock analysis
When running RAPT Therapeutics' price analysis, check to measure RAPT Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy RAPT Therapeutics is operating at the current time. Most of RAPT Therapeutics' value examination focuses on studying past and present price action to predict the probability of RAPT Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move RAPT Therapeutics' price. Additionally, you may evaluate how the addition of RAPT Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |
Is RAPT Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of RAPT Therapeutics. If investors know RAPT will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about RAPT Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (3.05) | Quarterly Revenue Growth (1.00) | Return On Assets (0.36) | Return On Equity (0.60) |
The market value of RAPT Therapeutics is measured differently than its book value, which is the value of RAPT that is recorded on the company's balance sheet. Investors also form their own opinion of RAPT Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is RAPT Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because RAPT Therapeutics' market value can be influenced by many factors that don't directly affect RAPT Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between RAPT Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if RAPT Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, RAPT Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.